Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 14, Issue 10, Pages 982-996
Publisher
Informa UK Limited
Online
2013-09-13
DOI
10.4161/cbt.26234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Proposal Regarding Reporting of In Vitro Testing Results
- (2013) M. A. Smith et al. CLINICAL CANCER RESEARCH
- Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes
- (2012) Marco Beauséjour et al. APOPTOSIS
- A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer
- (2012) A A Chiappori et al. BRITISH JOURNAL OF CANCER
- Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis
- (2012) Katharine L. Sodek et al. CANCER AND METASTASIS REVIEWS
- Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives
- (2012) Giuseppe Giannini et al. Future Medicinal Chemistry
- Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells
- (2012) Lifeng Feng et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression
- (2012) Dario Barbone et al. PLoS One
- Cell surface adhesion molecules and adhesion-initiated signaling: Understanding of anoikis resistance mechanisms and therapeutic opportunities
- (2011) Xiaoling Zhong et al. CELLULAR SIGNALLING
- Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage
- (2011) Daniel R. Premkumar et al. MOLECULAR CARCINOGENESIS
- Novel Anti-cancer Compounds for Developing Combinatorial Therapies to Target Anoikis-Resistant Tumors
- (2011) Lokesh Nagaprashantha et al. PHARMACEUTICAL RESEARCH
- Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy
- (2010) Aditi Pandya Martin et al. CANCER BIOLOGY & THERAPY
- Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
- (2010) Clint Mitchell et al. CANCER BIOLOGY & THERAPY
- A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
- (2010) Paul K. Paik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species-Dependent Signaling Pathway
- (2010) M. A. Park et al. CANCER RESEARCH
- Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma
- (2010) J. J. Hwang et al. CLINICAL CANCER RESEARCH
- Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis
- (2010) Sameer A. Parikh et al. Clinical Lymphoma Myeloma & Leukemia
- ErbB2 requires integrin 5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells
- (2010) K. K. Haenssen et al. JOURNAL OF CELL SCIENCE
- Hypoxia Suppression of Bim and Bmf Blocks Anoikis and Luminal Clearing during Mammary Morphogenesis
- (2010) Kelly A. Whelan et al. MOLECULAR BIOLOGY OF THE CELL
- HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA
- (2009) P Fritsche et al. GUT
- Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
- (2008) S. M. O'Brien et al. BLOOD
- Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
- (2008) Amel Baya Bouzar et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies
- (2008) A. D. Schimmer et al. CLINICAL CANCER RESEARCH
- Lapatinib Resistance in HCT116 Cells Is Mediated by Elevated MCL-1 Expression and Decreased BAK Activation and Not by ERBB Receptor Kinase Mutation
- (2008) A. P. Martin et al. MOLECULAR PHARMACOLOGY
- Induction of Autophagy during Extracellular Matrix Detachment Promotes Cell Survival
- (2007) Christopher Fung et al. MOLECULAR BIOLOGY OF THE CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started